Other studies also have shown cytokine release symptoms elicited by CAMPATH-1 to become isotype reliant, with human being IgG1 and rat IgG2b antibodies eliciting the most powerful response that could be inhibited with an anti-CD16 antibody (FcRIII), to stop cross-linking using the Compact disc16 FcR (24)

Other studies also have shown cytokine release symptoms elicited by CAMPATH-1 to become isotype reliant, with human being IgG1 and rat IgG2b antibodies eliciting the…